EPISODE · Sep 28, 2025 · 7 MIN
The Oddities and Ripple Effect of GLP-1
from Microdosing · host Paul Schrimpf
From weight loss buzz to healthcare infrastructure, GLP-1 drugs started as diabetes treatments but are now reshaping weight loss, care delivery, and consumer markets. In this episode, we explore how they have become more than medicine, driving new business models, digital access points, and patient expectations, featuring insights from leaders across health plans, startups, and strategy firms.
What this episode covers
From weight loss buzz to healthcare infrastructure, GLP-1 drugs started as diabetes treatments but are now reshaping weight loss, care delivery, and consumer markets. In this episode, we explore how they have become more than medicine, driving new business models, digital access points, and patient expectations, featuring insights from leaders across health plans, startups, and strategy firms.
NOW PLAYING
The Oddities and Ripple Effect of GLP-1
No transcript for this episode yet
Similar Episodes
Jun 10, 2026 ·121m
Jun 5, 2026 ·42m
May 20, 2026 ·58m